A detailed history of Washington Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Washington Trust CO holds 30,618 shares of ABBV stock, worth $6.03 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
30,618
Previous 33,262 7.95%
Holding current value
$6.03 Million
Previous $6.06 Million 13.31%
% of portfolio
0.19%
Previous 0.22%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

SELL
$154.79 - $180.76 $409,264 - $477,929
-2,644 Reduced 7.95%
30,618 $5.25 Million
Q1 2024

Apr 23, 2024

SELL
$159.82 - $182.1 $23,173 - $26,404
-145 Reduced 0.43%
33,262 $6.06 Million
Q4 2023

Jan 18, 2024

BUY
$137.6 - $154.97 $355,833 - $400,752
2,586 Added 8.39%
33,407 $5.18 Million
Q3 2023

Oct 18, 2023

SELL
$133.59 - $154.65 $13,359 - $15,465
-100 Reduced 0.32%
30,821 $4.59 Million
Q2 2023

Jul 27, 2023

SELL
$132.51 - $164.9 $74,603 - $92,838
-563 Reduced 1.79%
30,921 $4.17 Million
Q1 2023

May 10, 2023

BUY
$144.61 - $166.54 $4.5 Million - $5.18 Million
31,126 Added 97268.75%
31,158 $4.97 Million
Q1 2023

May 04, 2023

SELL
$144.61 - $166.54 $4.55 Million - $5.24 Million
-31,452 Reduced 99.9%
32 $4.97 Million
Q4 2022

Jul 27, 2023

BUY
$138.31 - $165.87 $45,089 - $54,073
326 Added 1.05%
31,484 $5.09 Million
Q4 2022

Feb 08, 2023

SELL
$138.31 - $165.87 $174,547 - $209,327
-1,262 Reduced 3.85%
31,484 $5.09 Million
Q3 2022

Oct 14, 2022

SELL
$134.21 - $153.93 $83,612 - $95,898
-623 Reduced 1.87%
32,746 $4.4 Million
Q2 2022

Jul 25, 2022

BUY
$137.62 - $174.96 $48,304 - $61,410
351 Added 1.06%
33,369 $5.11 Million
Q1 2022

May 05, 2022

SELL
$131.98 - $163.75 $161,147 - $199,938
-1,221 Reduced 3.57%
33,018 $5.35 Million
Q4 2021

Feb 09, 2022

SELL
$107.43 - $135.93 $2.01 Million - $2.54 Million
-18,697 Reduced 35.32%
34,239 $4.64 Million
Q3 2021

Nov 09, 2021

SELL
$106.4 - $120.78 $101,931 - $115,707
-958 Reduced 1.78%
52,936 $5.71 Million
Q2 2021

Aug 05, 2021

BUY
$105.21 - $117.21 $229,463 - $255,635
2,181 Added 4.22%
53,894 $6.07 Million
Q1 2021

Apr 28, 2021

SELL
$102.3 - $112.62 $31,099 - $34,236
-304 Reduced 0.58%
51,713 $5.6 Million
Q4 2020

Feb 09, 2021

SELL
$80.49 - $108.67 $203,720 - $275,043
-2,531 Reduced 4.64%
52,017 $5.57 Million
Q3 2020

Nov 05, 2020

SELL
$85.91 - $100.83 $117,524 - $137,935
-1,368 Reduced 2.45%
54,548 $4.78 Million
Q2 2020

Aug 04, 2020

SELL
$73.37 - $98.18 $268,387 - $359,142
-3,658 Reduced 6.14%
55,916 $5.42 Million
Q1 2020

May 07, 2020

BUY
$64.5 - $97.79 $214,849 - $325,738
3,331 Added 5.92%
59,574 $4.54 Million
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $1.17 Million - $1.46 Million
16,156 Added 40.3%
56,243 $4.98 Million
Q3 2019

Nov 06, 2019

SELL
$62.98 - $75.72 $231,892 - $278,801
-3,682 Reduced 8.41%
40,087 $3.19 Million
Q2 2019

Aug 07, 2019

SELL
$65.7 - $83.98 $163,067 - $208,438
-2,482 Reduced 5.37%
43,769 $3.18 Million
Q1 2019

May 13, 2019

SELL
$77.14 - $90.79 $234,582 - $276,092
-3,041 Reduced 6.17%
46,251 $3.61 Million
Q4 2018

Feb 11, 2019

SELL
$77.85 - $96.01 $175,941 - $216,982
-2,260 Reduced 4.38%
49,292 $4.55 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $456,197 - $507,148
-5,131 Reduced 9.05%
51,552 $4.88 Million
Q2 2018

Aug 10, 2018

BUY
$89.78 - $106.23 $379,230 - $448,715
4,224 Added 8.05%
56,683 $5.25 Million
Q1 2018

May 10, 2018

SELL
$92.01 - $123.21 $401,623 - $537,811
-4,365 Reduced 7.68%
52,459 $4.97 Million
Q4 2017

Feb 05, 2018

SELL
$89.56 - $98.21 $373,286 - $409,339
-4,168 Reduced 6.83%
56,824 $5.5 Million
Q3 2017

Oct 31, 2017

BUY
$69.85 - $89.22 $4.26 Million - $5.44 Million
60,992
60,992 $5.42 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $348B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Washington Trust CO Portfolio

Follow Washington Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust CO with notifications on news.